BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 22532501)

  • 1. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.
    Jiang Y; Xia WB; Xing XP; Silva BC; Li M; Wang O; Zhang HB; Li F; Jing HL; Zhong DR; Jin J; Gao P; Zhou L; Qi F; Yu W; Bilezikian JP; Meng XW
    J Bone Miner Res; 2012 Sep; 27(9):1967-75. PubMed ID: 22532501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
    J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced osteomalacia originating from the temporal bone: a case report.
    Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
    Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.
    Wang H; Zhong D; Liu Y; Jiang Y; Qiu G; Weng X; Xing X; Li M; Meng X; Li F; Zhu Z; Yu W; Xia W; Jin J
    J Bone Joint Surg Am; 2015 Jul; 97(13):1084-94. PubMed ID: 26135075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
    Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
    Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
    Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
    World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
    Li DM; Wu HW; Li JD; Xia WB; Jiang Y; Zhong DR
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):427-431. PubMed ID: 29886586
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
    Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
    Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
    Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
    J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.